MSN, Neurology Live highlight UC Parkinson's trial results
MSN and Neurology Live covered the results of a phase 3 trial co-led by a University of Cincinnati researcher that found Parkinson’s disease medication delivered through an infusion pump is safe and effective at reducing symptoms for longer periods of time.
The trial, led by UC's Alberto Espay, MD, found that 24-hour, continuous levodopa delivered through a subcutaneous infusion pump led to nearly two additional hours per day of "on time," or the time when the medication is working and symptoms are lessened, compared to taking levodopa orally.
“Levodopa is a replacement strategy. We all make levodopa, but Parkinson's patients make less of it,” said Espay, co-principal investigator of the trial, James J. and Joan A. Gardner Family Center for Parkinson’s Disease Research Endowed Chair in UC’s Department of Neurology and Rehabilitation Medicine and a physician at the UC Gardner Neuroscience Institute.
“Once approved, this will become an important treatment strategy to consider for patients with Parkinson’s disease experiencing motor fluctuations not adequately controlled with medication,” Espay continued. “Future studies will need to determine the durability of the long-term benefits and whether any safety issues could emerge, as well as how it might compare with deep brain stimulation.”
Read the MSN story, originally published on News Medical.
Read the Neurology Live story.
Healio, Physicians Weekly, Parkinson's News Today and Cleveland.com also covered the research.
Read the Parkinson's News Today article.
Read the Physicians Weekly article, originally published on Health Day.
Featured photo at top of 3-D illustration of a dopamine molecule. Photo/Dr_Microbe/iStock.
Related Stories
The hottest toys this holiday season
December 15, 2025
Local 12 turned to Lindner College of Business associate professor-educator of marketing Roseann Hassey to explain what’s got the trendiest items flying off the shelves.
Leukemia and Drug Development Lab trains the next generation of scientific researchers
December 15, 2025
From undergraduate student workers to members of the Physician Scientist Training Program (PSTP), trainees in UC's Leukemia and Drug Development Lab shared their experiences of in-depth, hands-on training that contribute to real-world discoveries.
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.